TCM — TCM A/S Income Statement
0.000.00%
- DKK724.58m
- DKK1.00bn
- DKK1.20bn
- 95
- 71
- 80
- 97
Annual income statement for TCM A/S, fiscal year end - December 31st, DKK millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | 2022 December 31st | C2023 December 31st | 2024 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 1,025 | 1,108 | 1,146 | 1,084 | 1,204 |
Cost of Revenue | |||||
Gross Profit | 273 | 255 | 234 | 216 | 255 |
Selling / General / Administrative Expenses | |||||
Depreciation and Amortization | |||||
Unusual Expense / Income | |||||
Other Operating Expenses | |||||
Total Operating Expenses | 890 | 970 | 1,049 | 1,038 | 1,113 |
Operating Profit | 135 | 138 | 96.9 | 45.8 | 90.3 |
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | 131 | 136 | 89.4 | 27.1 | 69.4 |
Provision for Income Taxes | |||||
Net Income After Taxes | 102 | 111 | 70.5 | 21.5 | 57.7 |
Net Income Before Extraordinary Items | |||||
Net Income | 102 | 111 | 70.5 | 21.5 | 57.7 |
Adjustments to Net Income | |||||
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | 102 | 111 | 70.5 | 21.5 | 57.7 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | 10.6 | 12 | 8.34 | 3.27 | 5.52 |
Dividends per Share |